Success and safety of high infliximab trough levels in inflammatory bowel disease.

David DrobneTina KurentSasa GolobPolona SveglPolona RajarSara TerzicMatic KozeljGregor NovakNatasa SmrekarSamo PlutNejc SeverLuka StrnisaJurij HanzelJernej BreceljDarja UrlepJosko OsredkarMatjaz HomanRok OrelBorut StabucIvan FerkoljAlojz Smid

Published in: Scandinavian journal of gastroenterology (2018)

High infliximab trough levels provide better control of inflammation in inflammatory bowel disease without increasing the risk of infection.

Keyphrases

oxidative stress
ulcerative colitis